Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ASNSNASDAQ:ASNSNASDAQ:CGTXNYSE:LODE On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeASNSActelis Networks$0.60+3.3%$0.69$0.53▼$2.21$5.45M1.91716,867 shs31,226 shsASNSActelis Networks$0.60+3.3%$0.69$0.53▼$2.21$5.45M1.91716,867 shs31,226 shsCGTXCognition Therapeutics$0.45+35.4%$0.33$0.22▼$2.54$25.11M0.882.84 million shs14.39 million shsLODEComstock$3.74-1.8%$3.15$1.26▼$10.10$121.56M1.57622,730 shs130,566 shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceASNSActelis Networks0.00%+0.17%-15.55%-1.67%+59,999,900.00%ASNSActelis Networks0.00%+0.17%-15.55%-1.67%+59,999,900.00%CGTXCognition Therapeutics0.00%+51.33%+56.50%+28.18%-74.35%LODEComstock0.00%-3.11%+16.88%+97.88%+133.90%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationASNSActelis Networks2.3561 of 5 stars3.55.00.00.00.60.00.6ASNSActelis Networks2.3561 of 5 stars3.55.00.00.00.60.00.6CGTXCognition Therapeutics2.7894 of 5 stars3.53.00.00.02.31.70.6LODEComstock1.5082 of 5 stars3.00.00.00.02.70.00.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceASNSActelis Networks 3.00Buy$5.00733.33% UpsideASNSActelis Networks 3.00Buy$5.00733.33% UpsideCGTXCognition Therapeutics 3.00Buy$2.83524.08% UpsideLODEComstock 2.00Hold$26.00595.19% UpsideCurrent Analyst Ratings BreakdownLatest LODE, CGTX, ASNS, and ASNS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/26/2025CGTXCognition TherapeuticsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$3.005/27/2025CGTXCognition TherapeuticsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$5.00 ➝ $3.005/8/2025CGTXCognition TherapeuticsChardan CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$8.00 ➝ $4.00(Data available from 7/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookASNSActelis Networks$7.76M0.71N/AN/A$0.36 per share1.67ASNSActelis Networks$7.76M0.71N/AN/A$0.36 per share1.67CGTXCognition TherapeuticsN/AN/AN/AN/A$0.31 per shareN/ALODEComstock$3.38M35.91N/AN/A$0.68 per share5.50Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateASNSActelis Networks-$4.37M-$0.56N/AN/AN/A-53.20%-181.28%-50.88%8/13/2025 (Estimated)ASNSActelis Networks-$4.37M-$0.56N/AN/AN/A-53.20%-181.28%-50.88%8/13/2025 (Estimated)CGTXCognition Therapeutics-$33.97M-$0.74N/AN/AN/AN/A-194.42%-115.14%8/6/2025 (Estimated)LODEComstock$9.16M-$1.20N/AN/AN/A-1,210.13%-33.56%-23.62%N/ALatest LODE, CGTX, ASNS, and ASNS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2025Q1 2025ASNSActelis Networks-$0.25-$0.22+$0.03-$0.22$1.20 million$0.72 million5/13/2025Q1 2025ASNSActelis Networks-$0.25-$0.22+$0.03-$0.22$1.20 million$0.72 million5/6/2025Q1 2025CGTXCognition Therapeutics-$0.12-$0.14-$0.02-$0.14N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthASNSActelis NetworksN/AN/AN/AN/AN/AASNSActelis NetworksN/AN/AN/AN/AN/ACGTXCognition TherapeuticsN/AN/AN/AN/AN/ALODEComstockN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioASNSActelis Networks0.061.560.89ASNSActelis Networks0.061.560.89CGTXCognition TherapeuticsN/A2.092.09LODEComstock0.162.452.45Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipASNSActelis Networks12.43%ASNSActelis Networks12.43%CGTXCognition Therapeutics43.35%LODEComstock7.96%Insider OwnershipCompanyInsider OwnershipASNSActelis Networks2.90%ASNSActelis Networks2.90%CGTXCognition Therapeutics14.40%LODEComstock4.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableASNSActelis Networks409.21 million8.95 millionN/AASNSActelis Networks409.21 million8.95 millionN/ACGTXCognition Therapeutics2061.99 million53.07 millionNot OptionableLODEComstock3032.42 million215.10 millionOptionableLODE, CGTX, ASNS, and ASNS HeadlinesRecent News About These CompaniesComstock set to join Russell Microcap IndexJuly 1, 2025 | msn.comComstock Inc. to Join Russell Microcap® Index Effective June 30, 2025June 30, 2025 | quiverquant.comQComstock Set to Join Russell Microcap® IndexJune 30, 2025 | globenewswire.comComstock Inc.: Comstock Metals and Virtus Renewables Form Strategic Solar Recycling PartnershipJune 25, 2025 | finanznachrichten.deComstock Metals and Virtus Renewables Form Strategic Solar Recycling PartnershipJune 24, 2025 | globenewswire.comKingswood Wealth Advisors LLC Has $66,000 Position in Comstock Inc. (NYSE:LODE)June 24, 2025 | marketbeat.comComstock (NYSE:LODE) Stock Price Down 4.6% - Here's What HappenedJune 24, 2025 | marketbeat.comThis Nevada town’s downtown just made HGTV’s list of most charming small town main streetsJune 18, 2025 | msn.comWhere does Northern Nevada end and Southern Nevada begin? Take the pollJune 14, 2025 | msn.comComstock Inc.: Comstock Amends Agreement With Mackay Precious Metals Inc.June 10, 2025 | finanznachrichten.deComstock Inc. Amends Agreement for $2.95 Million Sale of Northern Mining Claims to Mackay Precious Metals Inc.June 9, 2025 | quiverquant.comQComstock Amends Agreement With Mackay Precious Metals Inc.June 9, 2025 | globenewswire.comWhy this Nevada city is a must-visit for the funky side of lifeJune 7, 2025 | msn.comComstock Inc. Subsidiary Comstock Metals Receives Approval for Expanded Solar Panel Storage Facility in NevadaJune 5, 2025 | quiverquant.comQComstock Metals Receives Expanded County Storage Permit for Recycling Ramp UpJune 5, 2025 | globenewswire.comThis Nevada Saloon Is An Underrated Attraction With Live Music And An Abandoned Gold Mine In The BackJune 5, 2025 | msn.comComstock Inc. at Lytham Partners: Strategic Growth in Metals and FuelsMay 30, 2025 | investing.comComstock Mining Completes Separation of Renewable Fuels SegmentMay 28, 2025 | tipranks.comComstock, United States Antimony among materials stocks to join Russell Microcap Index; Ur Energy to leaveMay 28, 2025 | msn.comVirginia City recounts the Comstock’s influence on civil war this Memorial DayMay 27, 2025 | carsonnow.orgCComstock Inc. Announces Successful Separation of Renewable Fuels Segment, Launches Bioleum CorporationMay 22, 2025 | quiverquant.comQNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWhy BigBear.ai Could Rally 100% and Catch Palantir SoonBy Gabriel Osorio-Mazilli | June 30, 2025View Why BigBear.ai Could Rally 100% and Catch Palantir SoonIPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBy Dan Schmidt | June 20, 2025View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBigBear.ai Poised to Benefit as Palantir Dominates AI DefenseBy Gabriel Osorio-Mazilli | June 23, 2025View BigBear.ai Poised to Benefit as Palantir Dominates AI DefenseIntel's Turnaround Strategy Shifts From Planning to Attack ModeBy Jeffrey Neal Johnson | June 20, 2025View Intel's Turnaround Strategy Shifts From Planning to Attack ModeAre NVIDIA's Ethernet Wins Signs of Hope or Horror for Arista?By Leo Miller | June 6, 2025View Are NVIDIA's Ethernet Wins Signs of Hope or Horror for Arista?LODE, CGTX, ASNS, and ASNS Company DescriptionsActelis Networks NASDAQ:ASNS$0.60 +0.02 (+3.34%) Closing price 07/3/2025 02:14 PM EasternExtended Trading$0.58 -0.02 (-3.33%) As of 07/3/2025 04:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Actelis Networks, Inc. engages in the design, development, manufacture, and marketing of cyber hardened, hybrid fiber, networking solutions for Internet of Things and telecommunication companies in North America, Europe, the Middle East, Israel, and the Asia Pacific. It provides rapid-deployment networking solutions for wide-area IoT applications, including federal, state, and local governments; intelligent traffic systems; and military, utility, rail, telecom, and campus applications. The company's products include ethernet access devices; network aggregator switches; and Advanced MetaLIGHT/ Gigaline element management systems software, which enables remote management, monitoring, maintenance, and configuration of the installed equipment in the network. It also offers dynamic spectral software; and access broadband equipment. It serves offers its products through system integrators, distributors, contractors, resellers, and consultants. The company was incorporated in 1998 and is headquartered in Fremont, California.Actelis Networks NASDAQ:ASNS$0.60 +0.02 (+3.34%) Closing price 07/3/2025 02:14 PM EasternExtended Trading$0.58 -0.02 (-3.33%) As of 07/3/2025 04:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Actelis Networks, Inc. engages in the design, development, manufacture, and marketing of cyber hardened, hybrid fiber, networking solutions for Internet of Things and telecommunication companies in North America, Europe, the Middle East, Israel, and the Asia Pacific. It provides rapid-deployment networking solutions for wide-area IoT applications, including federal, state, and local governments; intelligent traffic systems; and military, utility, rail, telecom, and campus applications. The company's products include ethernet access devices; network aggregator switches; and Advanced MetaLIGHT/ Gigaline element management systems software, which enables remote management, monitoring, maintenance, and configuration of the installed equipment in the network. It also offers dynamic spectral software; and access broadband equipment. It serves offers its products through system integrators, distributors, contractors, resellers, and consultants. The company was incorporated in 1998 and is headquartered in Fremont, California.Cognition Therapeutics NASDAQ:CGTX$0.45 +0.12 (+35.44%) Closing price 07/3/2025 03:58 PM EasternExtended Trading$0.45 0.00 (-0.44%) As of 07/3/2025 05:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, an orally delivered molecule modulator designed to penetrate the blood-brain barrier and bind selectively to the S2R complex, which is in Phase 2 clinical trial for the treatment of Alzheimer's disease, as well as geographic atrophy secondary to dry age-related macular degeneration and synucleinopathies, such as dementia with Lewy bodies. The company was incorporated in 2007 and is headquartered in Purchase, New York.Comstock NYSE:LODE$3.74 -0.07 (-1.84%) Closing price 07/3/2025 03:57 PM EasternExtended Trading$3.74 0.00 (0.00%) As of 07/3/2025 04:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Comstock Inc. engages in the systemic decarbonization business in Nevada and internationally. It operates through Renewable Energy, Mining, and Strategic and Other Investments segments. It will develop technology for the deploying of extraction and refining facilities that convert wasted and unused biomass and other natural resources; and a demonstration system to extract black mass containing lithium, graphite, nickel, cobalt, manganese, copper, aluminum, and other metals from up to lithium-ion batteries. The company also owns the Lucerne Project located in the Storey County, Nevada; and the Spring Valley Project situated in the Lyon County, Nevada. In addition, it offers upstream and downstream design, engineering, fabrication, procurement, and construction solutions; and invests in non-mining real estate investments. The company was incorporated in 2008 and is based in Virginia City, Nevada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/30 - 07/04 The Apple Comeback Will Be Better Than the Setback Micron’s Big Q3 Drives Applied Materials’ Bullish Outlook Why Occidental's Price Dip Signals a Buying Opportunity Qualcomm’s Hold Rating Misses Strong Growth Story Rigetti Computing: Cantor's Bullish Call May Be Just the Start Insider Selling at NVIDIA Could Turn Into an Opportunity Whiplash for Investors: AeroVironment's Confusing Stock Signals Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
